Skip to Content

MYLAN 507 (Hydrochlorothiazide and methyldopa 15 mg / 250 mg)

Pill imprint MYLAN 507 has been identified as Hydrochlorothiazide and methyldopa 15 mg / 250 mg.

Hydrochlorothiazide/methyldopa is used in the treatment of high blood pressure and belongs to the drug class antiadrenergic agents (central) with thiazides. Risk cannot be ruled out during pregnancy. Hydrochlorothiazide/methyldopa 15 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Hydrochlorothiazide and methyldopa 15 mg / 250 mg MYLAN 507
Hydrochlorothiazide and methyldopa 15 mg / 250 mg MYLAN 507
Discount Card Promo
Hydrochlorothiazide and methyldopa
Imprint:
MYLAN 507
Strength:
15 mg / 250 mg
Color:
Green
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antiadrenergic agents (central) with thiazides
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0507
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Yellow No. 6
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
triacetin

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide